Doximity EBITDA 2020-2024 | DOCS
- Doximity EBITDA for the quarter ending March 31, 2024 was $0.061B, a 41.39% increase year-over-year.
- Doximity EBITDA for the twelve months ending March 31, 2024 was $0.170B, a 19.65% increase year-over-year.
- Doximity 2024 annual EBITDA was $0.178B, a 20.7% increase from 2023.
- Doximity 2023 annual EBITDA was $0.147B, a 11.03% increase from 2022.
- Doximity 2022 annual EBITDA was $0.133B, a 107.01% increase from 2021.
Doximity Annual EBITDA (Millions of US $) |
|
---|---|
2024 | $178 |
2023 | $147 |
2022 | $133 |
2021 | $64 |
2020 | $28 |
2019 | $12 |
Doximity Quarterly EBITDA (Millions of US $) |
|
---|---|
2023-12-31 | $61 |
2023-09-30 | $37 |
2023-06-30 | $35 |
2023-03-31 | $38 |
2022-12-31 | $43 |
2022-09-30 | $38 |
2022-06-30 | $28 |
2022-03-31 | $33 |
2021-12-31 | $40 |
2021-09-30 | $30 |
2021-06-30 | $30 |
2021-03-31 | $16 |
2020-12-31 | $21 |
2020-09-30 | $13 |
2020-06-30 | $4 |
2020-03-31 | |
2019-03-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $5.107B | $0.475B |
Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $125.903B | 15.80 |
Cencora (COR) | United States | $47.741B | 18.61 |
ICON (ICLR) | Ireland | $26.139B | 24.68 |
DiDi Global (DIDIY) | China | $21.386B | 0.00 |
Avantor (AVTR) | United States | $15.283B | 22.50 |
CochLear (CHEOY) | Australia | $14.173B | 0.00 |
Revvity (RVTY) | United States | $13.191B | 23.14 |
Natera (NTRA) | United States | $13.190B | 0.00 |
Medpace Holdings (MEDP) | United States | $12.644B | 41.60 |
Viatris (VTRS) | United States | $12.466B | 3.73 |
Charles River Laboratories (CRL) | United States | $10.809B | 20.69 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $9.137B | 0.00 |
Solventum (SOLV) | United States | $8.860B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.681B | 0.00 |
HealthEquity (HQY) | United States | $7.198B | 46.21 |
Organon (OGN) | United States | $5.431B | 5.15 |
Bausch + Lomb (BLCO) | Canada | $5.256B | 21.04 |
PACS (PACS) | United States | $4.437B | 0.00 |
Life Times (LTH) | United States | $3.623B | 37.96 |
Sotera Health (SHC) | United States | $3.369B | 16.53 |
Surgery Partners (SGRY) | United States | $3.017B | 27.60 |
GoodRx Holdings (GDRX) | United States | $2.859B | 108.86 |
Agilon Health (AGL) | United States | $2.677B | 0.00 |
Progyny (PGNY) | United States | $2.487B | 42.82 |
AMN Healthcare Services Inc (AMN) | United States | $2.029B | 8.04 |
NovoCure (NVCR) | Jersey | $2.014B | 0.00 |
Premier (PINC) | United States | $1.949B | 8.34 |
BrightSpring Health Services (BTSG) | United States | $1.852B | 0.00 |
Teladoc Health (TDOC) | United States | $1.757B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
Alignment Healthcare (ALHC) | United States | $1.449B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
CareDx (CDNA) | United States | $0.749B | 0.00 |
Embecta (EMBC) | United States | $0.722B | 4.91 |
GeneDx Holdings (WGS) | United States | $0.717B | 0.00 |
InnovAge Holding (INNV) | United States | $0.695B | 0.00 |
Pediatrix Medical (MD) | United States | $0.680B | 7.21 |
Auna S.A (AUNA) | Luxembourg | $0.568B | 0.00 |
Sharecare (SHCR) | United States | $0.497B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
COMPASS Pathways (CMPS) | United Kingdom | $0.430B | 0.00 |
Enhabit (EHAB) | United States | $0.426B | 42.50 |
ModivCare (MODV) | United States | $0.367B | 6.87 |
Sonida Senior Living (SNDA) | United States | $0.345B | 0.00 |
DocGo (DCGO) | United States | $0.310B | 16.94 |
LifeMD (LFMD) | United States | $0.288B | 0.00 |
MultiPlan (MPLN) | United States | $0.238B | 0.00 |
Beauty Health (SKIN) | United States | $0.223B | 0.00 |
Sera Prognostics (SERA) | United States | $0.212B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.204B | 0.00 |
Biodesix (BDSX) | United States | $0.189B | 0.00 |
So-Young (SY) | China | $0.111B | 53.49 |
Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
NeueHealth (NEUE) | United States | $0.044B | 5.88 |
Co-Diagnostics (CODX) | United States | $0.043B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.035B | 0.00 |
Oncology Institute (TOI) | United States | $0.031B | 0.00 |
Nutex Health (NUTX) | United States | $0.029B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.023B | 0.00 |
OncoCyte (OCX) | United States | $0.022B | 0.00 |
KindlyMD (KDLY) | $0.018B | 0.00 | |
BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
TRxADE HEALTH (MEDS) | United States | $0.012B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
ISpecimen (ISPC) | United States | $0.005B | 0.00 |
DermTech (DMTK) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
OpGen (OPGN) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Assure Holdings (IONM) | United States | $0.002B | 0.00 |